Q3 2019 Fagron NV Corporate Sales Call Transcript
Good day, and welcome to the Fagron Trading Update Q3 Results 2019 Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Rafael Padilla, CEO. Please go ahead, sir.
Thank you very much. Hello, and good morning, everyone. Thank you for calling for the Q3 trading update. Today, Constantijn, Karin and myself are very pleased to announce and state with you our first semester update, an acceleration of our top line during the second semester that proves the success of our clear strategy. All regions have performed as planned, and we would like to remark the growth in Europe, driven by the restart of our sales facility in the Netherlands and a strong growth in the Brands segment, driven by a clear strategic focus, together with the promising start of Fagron Genomics.
In North America, we have reached an important milestone by getting a run rate $50 million sales in our Fagron Sterile Services division. Anazao has performed very well, growing almost 7%.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
